Phio Pharmaceuticals Corp... (PHIO)
Phio Pharmaceuticals Statistics
Share Statistics
Phio Pharmaceuticals has 4.78M shares outstanding. The number of shares has increased by 4.03% in one year.
| Shares Outstanding | 4.78M |
| Shares Change (YoY) | 4.03% |
| Shares Change (QoQ) | 175.73% |
| Owned by Institutions (%) | 4.22% |
| Shares Floating | 4.23M |
| Failed to Deliver (FTD) Shares | 463.48K |
| FTD / Avg. Volume | 15.44% |
Short Selling Information
The latest short interest is 1.44M, so 30.09% of the outstanding shares have been sold short.
| Short Interest | 1.44M |
| Short % of Shares Out | 30.09% |
| Short % of Float | 30.11% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -1.98 and the forward PE ratio is null. Phio Pharmaceuticals's PEG ratio is 0.02.
| PE Ratio | -1.98 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 3 |
| P/FCF Ratio | -1.99 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Phio Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.65, with a Debt / Equity ratio of 0.
| Current Ratio | 5.65 |
| Quick Ratio | 5.65 |
| Debt / Equity | 0 |
| Debt / EBITDA | - |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.43M |
| Employee Count | 5 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -72.78% in the last 52 weeks. The beta is 1.08, so Phio Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 1.08 |
| 52-Week Price Change | -72.78% |
| 50-Day Moving Average | 1.6 |
| 200-Day Moving Average | 2.5 |
| Relative Strength Index (RSI) | 49.8 |
| Average Volume (20 Days) | 3M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -7.15M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.91 |
Balance Sheet
The company has 5.38M in cash and 0 in debt, giving a net cash position of 5.38M.
| Cash & Cash Equivalents | 5.38M |
| Total Debt | 0 |
| Net Cash | 5.38M |
| Retained Earnings | -146.36M |
| Total Assets | 5.74M |
| Working Capital | 4.72M |
Cash Flow
In the last 12 months, operating cash flow was -7.11M and capital expenditures -1K, giving a free cash flow of -7.11M.
| Operating Cash Flow | -7.11M |
| Capital Expenditures | -1K |
| Free Cash Flow | -7.11M |
| FCF Per Share | -0.9 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PHIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PHIO is $4, which is 110.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $4 |
| Price Target Difference | 110.5% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 5, 2024. It was a backward split with a ratio of 1:9.
| Last Split Date | Jul 5, 2024 |
| Split Type | backward |
| Split Ratio | 1:9 |
Scores
| Altman Z-Score | -32.89 |
| Piotroski F-Score | 1 |